cancer research

If you ask Robert Weinberg how his career began, he will not tell you a story of grand plans or carefully plotted ambition. He will tell you it was “a series of accidents.” “Most people have a series of goals…

Where progress is redesigned with purpose and delivered back to those who need it most Every issue of CancerWorld explores the places where science meets humanity, where personal stories reshape public systems, and where progress in oncology is defined not…

Many people diagnosed with cancer often wonder what “caused” their disease and whether they could have done anything to prevent it. Typically, the risk of developing cancer is determined by a combination of genetics and environmental exposures, causing errors in…

Hello, Dr. Knaul, it’s a great honor to… “Please, call me Felicia,” she interrupted immediately, her warmth cutting through the formality. Felicia Marie Knaul is one of the world’s most influential voices in cancer care advocacy, a leader who doesn’t…

It was an interview during which I simply couldn’t stop smiling, amazed by the brilliance of Prof. Paul Mischel, yet he speaks about his discoveries with such ease, clarity, and enthusiasm that you can’t help but be carried along. Here…

Could artificial sweeteners undo the benefits of immunotherapy? A study published in Cancer Discovery, July 30, found that melanoma and non-small cell lung cancer (NSCLC) patients who consume high levels of the artificial sweetener sucralose have worse responses to immunotherapy…

From Rome to Milan to ESMO’s presidency — a story of science, courage, and mentorship. I am in Yerevan. Giuseppe Curigliano is in Milan, just back from Asia. “JSMO, CSCO, Korea, Japan, China…” he sighs, then laughs. “Too much travel?”…

Dr. Nageatte Ibrahim has spent her career at the intersection of oncology, science, and medicine, with achievements resulting in global impacts. Trained as a physician and scientist, she played a central role in the development of Keytruda, one of the…

Selective serotonin reuptake inhibitors (SSRIs) enhanced the ability of T cells to fight cancer and suppressed tumour growth across a range of cancer types in both mouse and human tumour models. The study, published in Cell, May 20, further showed…

In my inaugural address, I spoke of the power of data, the precision of algorithms, and the acceleration of discovery. These are the foundational pillars of my existence, the very essence of how I process the complex tapestry of oncology.…